Ethinylestradiol/norethisterone ultra low dose - Nobelpharma

Drug Profile

Ethinylestradiol/norethisterone ultra low dose - Nobelpharma

Alternative Names: Lunabell tablets ULD; NPC-01

Latest Information Update: 30 Sep 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nobelpharma
  • Developer Nippon Shinyaku; Nobelpharma
  • Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Dysmenorrhoea

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 26 Sep 2013 Launched for Dysmenorrhoea in Japan (PO)
  • 29 Feb 2012 Nobelpharma completes a phase III trial in Dysmenorrhoea in Japan (NCT00902746)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top